Bristol Myers Squibb Co Trademarks & Logos

Mark Image Registration \| Serial	Trademark Application Date
"XIGTUA" 85558525	XIGTUA 2012-03-02
"BINZIGA" 85558503	BINZIGA 2012-03-02
"XIGTUVO" 85558529	XIGTUVO 2012-03-02
"DUFORGA" 85558506	DUFORGA 2012-03-02
"XIGUMET" 85558531	XIGUMET 2012-03-02
"SIGDUA" 85558510	SIGDUA 2012-03-02
"XINFORX" 85558537	XINFORX 2012-03-02
"XIGATU" 85558514	XIGATU 2012-03-02
"Symbol/Image" 85554997	Symbol/Image 2012-02-28
"TOGE+HER" 4526255 85554889	TOGE+HER 2012-02-28
"EVOLUTIONS IN QUALITY CANCER SUPPORT" 85554920	EVOLUTIONS IN QUALITY CANCER SUPPORT 2012-02-28
"DIABETRAK" 85554946	DIABETRAK 2012-02-28
"DIABETRAK" 85554986	DIABETRAK 2012-02-28
"CEGAFUZE" 85549142	CEGAFUZE 2012-02-22
"DASIST" 85549232	DASIST 2012-02-22
"SEGAFUZE" 85549161	SEGAFUZE 2012-02-22
"COFUZIG" 85549144	COFUZIG 2012-02-22
"SYNXIGA" 85549164	SYNXIGA 2012-02-22
"DUFORSIG" 85549146	DUFORSIG 2012-02-22
"SETZIGA" 85549211	SETZIGA 2012-02-22
"FORDUEX" 85549152	FORDUEX 2012-02-22
"ADZIGA" 85549127	ADZIGA 2012-02-22
"DASCERN" 85549225	DASCERN 2012-02-22
"FORSYNZIG" 85549156	FORSYNZIG 2012-02-22
"CEGAFUSE" 85549139	CEGAFUSE 2012-02-22
"DASPERSE" 85549228	DASPERSE 2012-02-22
"SEGAFUSE" 85549159	SEGAFUSE 2012-02-22
"ELIQUIS" 4451882 85544142	ELIQUIS 2012-02-16
"Symbol/Image" 4451883 85544147	Symbol/Image 2012-02-16
"GOVOMNI" 85540634	GOVOMNI 2012-02-13
"APLURIZE" 85540630	APLURIZE 2012-02-13
"DASCOVERY" 4743918 85537861	DASCOVERY 2012-02-09
"DASCOVERY" 4743919 85537871	DASCOVERY 2012-02-09
"XIGADAP" 85536663	XIGADAP 2012-02-08
"XIGTUA" 85536656	XIGTUA 2012-02-08
"ESIGMET" 85536672	ESIGMET 2012-02-08
"XIGADAP" 85536649	XIGADAP 2012-02-08
"XIGATOTE" 85536664	XIGATOTE 2012-02-08
"XIGTUVO" 85536658	XIGTUVO 2012-02-08
"METXIGA" 85536675	METXIGA 2012-02-08
"XIGATOTE" 85536651	XIGATOTE 2012-02-08
"XIGSUM" 85536665	XIGSUM 2012-02-08
"XIFUZIG" 85536660	XIFUZIG 2012-02-08
"XIGSUM" 85536652	XIGSUM 2012-02-08
"XIFUZIG" 85536645	XIFUZIG 2012-02-08
"XIGMETYN" 85536667	XIGMETYN 2012-02-08
"XIGAFUZE" 85536661	XIGAFUZE 2012-02-08
"XIGMELD" 85536653	XIGMELD 2012-02-08
"XIGTUA" 85536668	XIGTUA 2012-02-08
"XIGAFUZE" 85536647	XIGAFUZE 2012-02-08
"XIGALYNC" 85536662	XIGALYNC 2012-02-08
"XIGMETYN" 85536655	XIGMETYN 2012-02-08
"ZIGFULDA" 85536671	ZIGFULDA 2012-02-08
"XIGALYNC" 85536648	XIGALYNC 2012-02-08
"MY NULOJIX NETWORK (BELATACEPT)" 4321946 85534365	MY NULOJIX NETWORK (BELATACEPT) 2012-02-06
"FOPARIG" 85532396	FOPARIG 2012-02-02
"XIGUMET" 85532332	XIGUMET 2012-02-02
"FUSIFORX" 85532403	FUSIFORX 2012-02-02
"METZIGA" 85532346	METZIGA 2012-02-02
"AVEMRY" 85532196	AVEMRY 2012-02-02
"BALYFORX" 85532371	BALYFORX 2012-02-02
"APEXAGUARD" 85532217	APEXAGUARD 2012-02-02
"FORXYTU" 85532380	FORXYTU 2012-02-02
"APEXIGUARD" 85532226	APEXIGUARD 2012-02-02
"FORXCO" 85532384	FORXCO 2012-02-02
"APEXAGARD" 85532236	APEXAGARD 2012-02-02
"AMPLIFY" 85530652	AMPLIFY 2012-02-01
"EXPANSE" 85530619	EXPANSE 2012-02-01
"EXPANSE" 85530636	EXPANSE 2012-02-01
"DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS" 85525586	DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS 2012-01-26
"DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS" 85525589	DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS 2012-01-26
"ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS A" 85525635	ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS A 2012-01-26
"ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND A" 85525643	ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND A 2012-01-26
"ONGLYZA" 85504669	ONGLYZA 2011-12-28
"SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE" 85499857	SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE 2011-12-20
"PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION" 4832089 85498760	PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION 2011-12-19
"E - ALL OF THE ABOVE" 85495086	E - ALL OF THE ABOVE 2011-12-14
"IT'S ABOUT THEIR ODDS" 85488361	IT'S ABOUT THEIR ODDS 2011-12-06
"M MELANOMA EXPOSED SCREEN. PROTECT. KNOW. TELL." 4614149 85481300	M MELANOMA EXPOSED SCREEN. PROTECT. KNOW. TELL. 2011-11-28
"M" 4491582 85471651	M 2011-11-14
"MELANOMA EXPOSED" 85471669	MELANOMA EXPOSED 2011-11-14
"POSITIVE CHARGE" 85465639	POSITIVE CHARGE 2011-11-07
"POSI+IVE CHARGE" 85464398	POSI+IVE CHARGE 2011-11-04
"PARTNERS IN DIABETES" 4146748 85462365	PARTNERS IN DIABETES 2011-11-02
"PROTECTION FOR YOUR KIDNEY TRANSPLANT MATTERS" 85452050	PROTECTION FOR YOUR KIDNEY TRANSPLANT MATTERS 2011-10-20
"AVENUE: AN INVESTIGATION AND UNDERSTANDING" 85439799	AVENUE: AN INVESTIGATION AND UNDERSTANDING 2011-10-05
"FACEHEPB.COM VÃ LÃ GAN CÃA QUÃ VI. HÃY HÃNH DÃNG NGAY" 4493240 85433704	FACEHEPB.COM VÃ LÃ GAN CÃA QUÃ VI. HÃY HÃNH DÃNG NGAY 2011-09-28
"MAKING A DISTINCT IMPRESSION" 85434235	MAKING A DISTINCT IMPRESSION 2011-09-28
"CHANGE THEIR ODDS" 85434249	CHANGE THEIR ODDS 2011-09-28
"IXEMPRA INVOLVE ME" 85432708	IXEMPRA INVOLVE ME 2011-09-27
"MEPLICITI" 85427807	MEPLICITI 2011-09-21
"MEPLICIT" 85416388	MEPLICIT 2011-09-07
"APLICITI" 85416397	APLICITI 2011-09-07
"BARACLUDE ALL IN ONE ACCESS PROGRAM" 4511145 85416437	BARACLUDE ALL IN ONE ACCESS PROGRAM 2011-09-07
"HALLMARK-QUAD" 4429252 85412909	HALLMARK-QUAD 2011-09-01
"HALLMARK-DAA" 85412921	HALLMARK-DAA 2011-09-01
"CUSTOMERS @ CENTER" 85407135	CUSTOMERS @ CENTER 2011-08-25
"FIND A STUDY" 4313867 85397766	FIND A STUDY 2011-08-15
"ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL" 85382237	ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL 2011-07-27
"IMAGE: IPILIMUMAB IN THE MANAGEMENT OF ADVANCED MELANOMA IN ACTUAL PRACTICE" 85380942	IMAGE: IPILIMUMAB IN THE MANAGEMENT OF ADVANCED MELANOMA IN ACTUAL PRACTICE 2011-07-26

Mark Image

Registration | Serial

Trademark

Application Date

"EVOLUTIONS IN QUALITY CANCER SUPPORT"

85554920

EVOLUTIONS IN QUALITY CANCER SUPPORT

"MY NULOJIX NETWORK (BELATACEPT)"

4321946 85534365

MY NULOJIX NETWORK (BELATACEPT)

"DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS"

85525586

DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS

2012-01-26

"DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS"

85525589

DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS

2012-01-26

"ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS A"

85525635

ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS A

2012-01-26

"ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND A"

85525643

ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND A

"SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE"

85499857

SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE

2011-12-20

"PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION"

4832089 85498760

PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION

2011-12-19

"E - ALL OF THE ABOVE"

85495086

E - ALL OF THE ABOVE

2011-12-14

"IT'S ABOUT THEIR ODDS"

85488361

IT'S ABOUT THEIR ODDS

2011-12-06

"M MELANOMA EXPOSED SCREEN. PROTECT. KNOW. TELL."

4614149 85481300

M MELANOMA EXPOSED SCREEN. PROTECT. KNOW. TELL.

"PARTNERS IN DIABETES"

4146748 85462365

PARTNERS IN DIABETES

2011-11-02

"PROTECTION FOR YOUR KIDNEY TRANSPLANT MATTERS"

85452050

PROTECTION FOR YOUR KIDNEY TRANSPLANT MATTERS

2011-10-20

"AVENUE: AN INVESTIGATION AND UNDERSTANDING"

85439799

AVENUE: AN INVESTIGATION AND UNDERSTANDING

2011-10-05

"FACEHEPB.COM VÃ LÃ GAN CÃA QUÃ VI. HÃY HÃNH DÃNG NGAY"

4493240 85433704

FACEHEPB.COM VÃ LÃ GAN CÃA QUÃ VI. HÃY HÃNH DÃNG NGAY

2011-09-28

"MAKING A DISTINCT IMPRESSION"

85434235

MAKING A DISTINCT IMPRESSION

"BARACLUDE ALL IN ONE ACCESS PROGRAM"

4511145 85416437

BARACLUDE ALL IN ONE ACCESS PROGRAM

"ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL"

85382237

ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL

2011-07-27

"IMAGE: IPILIMUMAB IN THE MANAGEMENT OF ADVANCED MELANOMA IN ACTUAL PRACTICE"

85380942

IMAGE: IPILIMUMAB IN THE MANAGEMENT OF ADVANCED MELANOMA IN ACTUAL PRACTICE

2011-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Bristol Myers Squibb Co

USPTO Trademark & Patent Filings